[
  {
    "question": "How is HIV diagnosed?",
    "answer": "## HIV Diagnosis\n\n Accurate diagnosis of HIV infection is crucial for early intervention, treatment, and prevention of transmission. Understanding the diagnostic process can help individuals seek timely medical attention and receive appropriate care.\n\n ### Diagnostic Challenges:\n - **Window Period**: The time between exposure to HIV and the appearance of detectable antibodies in the blood.\n - **False Negatives**: Can occur if testing is done during the window period.\n - **False Positives**: Rare, but can occur due to cross-reactivity with other substances.\n\n ### Diagnostic Tests:\n - **Combination Antigen/Antibody Tests**: \n   - **Rapid Tests**: Provide results within minutes.\n   - **Enzyme-Linked Immunosorbent Assay (ELISA)**: A laboratory-based test that detects HIV antibodies and antigens.\n   - **Western Blot**: A confirmatory test that detects specific HIV antibodies.\n - **Antibody Tests**: Detect HIV antibodies in the blood.\n - **Antigen Tests**: Detect HIV antigens (p24 protein) in the blood.\n\n ### Diagnostic Process:\n 1. **Initial Screening**: Combination antigen/antibody tests or antibody tests are used to screen for HIV.\n 2. **Confirmatory Testing**: Positive results are confirmed with Western blot or nucleic acid testing (NAT).\n 3. **Nucleic Acid Testing (NAT)**: Detects HIV genetic material in the blood.\n 4. **Repeat Testing**: If initial testing is negative, repeat testing may be necessary to confirm HIV status.\n\n ### Summary:\n HIV diagnosis involves a combination of tests to detect HIV antibodies and antigens, with confirmatory testing using Western blot or NAT to ensure accurate results.",
    "true_answer": "HIV is diagnosed through HIV testing. There are three types of tests used to diagnose HIV infection: antibody tests, antigen/antibody tests, and nucleic acid tests (NATs). How soon each test can detect HIV infection differs, because each test has a different window period. The window period is the time between when a person may have been exposed to HIV and when a test can accurately detect HIV infection. Window periods for different HIV tests are the followings: Antibody tests can usually detect HIV 23 to 90 days after exposure. Most rapid tests and self-tests are antibody tests. A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure. An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure. A NAT can usually detect HIV 10 to 33 days after exposure. When an HIV test is positive, a follow-up test will be conducted for confirmation. Sometimes people will need to visit a health care provider to take a follow-up test using another blood sample. Other times, the follow-up test may be performed in a lab using the original blood sample to ensure that the first positive result wasn\u2019t a false positive"
  },
  {
    "question": "What are the different stages of HIV?",
    "answer": "## Stages of HIV Infection\n\nHIV infection progresses through several stages, each with distinct characteristics and implications for treatment and management.\n\n### Natural History of HIV Infection\n\nThe natural history of HIV infection can be divided into three stages:\n\n1. **Acute HIV Infection**\n   - Characterized by a transient period of viremia, where the virus is actively replicating in the body.\n   - Typically occurs within 2-4 weeks after infection.\n   - Symptoms may include fever, rash, and swollen lymph nodes.\n\n2. **Chronic HIV Infection**\n   - Marked by a plateau in viral replication, where the virus is present in the body but not actively replicating.\n   - Can last for years or even decades without treatment.\n   - During this stage, the immune system gradually weakens, increasing the risk of opportunistic infections.\n\n3. **AIDS (Acquired Immunodeficiency Syndrome)**\n   - Occurs when the immune system is severely weakened, and the body is unable to fight off opportunistic infections.\n   - Characterized by a CD4 cell count below 200 cells/mm^3.\n   - Without treatment, AIDS is often fatal due to the development of life-threatening opportunistic infections and cancers.\n\n### Treatment and Progression\n\nWithout treatment, HIV infection progresses to AIDS in approximately 10 years. However, with antiretroviral therapy (ART), the progression to AIDS can be delayed indefinitely. By suppressing viral replication, ART can prevent the immune system from deteriorating and reduce the risk of opportunistic infections.",
    "true_answer": "The different stages of HIV are either defined as three: (1) acute HIV infection, (2) chronic HIV infection, and (3) acquired immunodeficiency syndrome (AIDS); or four: (1) acute HIV infection, (2) asymptomatic stage, (3) symptomatic HIV, and (4) Late-stage HIV or AIDS."
  },
  {
    "question": "How is HIV transmitted?",
    "answer": "## Understanding HIV Transmission\n\n HIV (Human Immunodeficiency Virus) transmission occurs when the virus enters the body and begins to replicate, eventually leading to the development of AIDS (Acquired Immunodeficiency Syndrome). It's essential to understand the modes of transmission to prevent the spread of the virus.\n\n ### Modes of HIV Transmission:\n HIV can be transmitted through various routes, including:\n\n ### 1. Sexual Contact:\n - **Vaginal or Anal Intercourse**: HIV can be transmitted through unprotected vaginal or anal sex with an infected partner.\n - **Oral Sex**: Although the risk is lower, HIV can be transmitted through oral sex with an infected partner.\n\n ### 2. Exposure to Contaminated Body Fluids:\n - **Blood**: HIV can be transmitted through exposure to contaminated blood, such as through sharing needles or syringes.\n - **Semen**: HIV can be transmitted through exposure to contaminated semen.\n - **Pre-seminal Fluid**: HIV can be transmitted through exposure to contaminated pre-seminal fluid.\n - **Rectal Secretions**: HIV can be transmitted through exposure to contaminated rectal secretions.\n - **Vaginal Secretions**: HIV can be transmitted through exposure to contaminated vaginal secretions.\n - **Breast Milk**: HIV can be transmitted through breast milk from an infected mother to her child.\n\n ### 3. Occupational Exposure:\n - **Healthcare Workers**: HIV can be transmitted through occupational exposure, such as needlestick injuries or exposure to contaminated blood or body fluids.\n\n ### 4. Mother-to-Child Transmission:\n - HIV can be transmitted from an infected mother to her child during pregnancy, childbirth, or breastfeeding.\n\n ### Summary:\n HIV transmission occurs through exposure to contaminated blood, semen, pre-seminal fluid, rectal secretions, vaginal secretions, or breast milk. Understanding these modes of transmission is crucial for preventing the spread of the virus.",
    "true_answer": "HIV is spread from the body fluids of an infected person, including blood, breast milk, semen and vaginal fluids. It can also spread from a mother to her baby."
  },
  {
    "question": "What comorbidities are common among people living with HIV?",
    "answer": "## Comorbidities in People Living with HIV\n\n People living with HIV are at an increased risk of developing various comorbidities due to the virus's impact on the immune system and the effects of antiretroviral therapy (ART). Understanding these comorbidities is crucial for providing comprehensive care and improving the overall health outcomes of individuals with HIV.\n\n ### Factors Contributing to Comorbidities:\n - **Immune System Suppression**: HIV infection compromises the immune system, making individuals more susceptible to infections and other health issues.\n - **Antiretroviral Therapy (ART)**: While ART is essential for managing HIV, it can also contribute to comorbidities, such as metabolic disorders and cardiovascular disease.\n\n ### Common Comorbidities:\n - **Mental Health Disorders**:\n   - Depression\n   - Anxiety\n   - Substance abuse disorders\n - **Infectious Diseases**:\n   - Bacterial pneumonia\n   - Tuberculosis\n   - Hepatitis B and C\n - **Metabolic Disorders**:\n   - Diabetes mellitus\n   - Dyslipidemia\n   - Obesity\n - **Cardiovascular Disease**:\n   - Atherosclerosis\n   - Heart failure\n - **Neurological Disorders**:\n   - Peripheral neuropathy\n   - Cognitive impairment\n - **Malignancies**:\n   - Non-Hodgkin lymphoma\n   - Kaposi's sarcoma\n   - Other cancers\n - **Chronic Kidney Disease**:\n   - Nephropathy\n   - Renal failure\n - **Osteoporosis**:\n   - Bone loss\n   - Fractures\n\n ### Summary:\n People living with HIV are at an increased risk of developing a range of comorbidities, which can significantly impact their quality of life and overall health outcomes. Early detection and management of these comorbidities are essential for providing comprehensive care and improving the health and well-being of individuals with HIV.",
    "true_answer": "The most common comorbidities amongst patients with HIV include: diabetes mellitus, cardiovascular disease (CVD, e.g. hypertension), respiratory diseases (e.g. chronic obstructive pulmonary diseases and pneumonia), and hepatic diseases (hepatitis B and C). Liver disease, renal disease, substance dependence and abuse, sexually transmitted infections (herpes simplex, syphilis, gonorrhoea and Mycoplasma genitalium) and psychiatric disorders (including depression, anxiety, schizophrenia and cognitive impairment) are also greater among HIV-positive individuals."
  },
  {
    "question": "How can HIV be prevented?",
    "answer": "## Preventing HIV Infection\n\nPreventing HIV infection involves a combination of behavioral and biomedical interventions. These strategies aim to reduce the transmission of HIV and decrease the risk of infection.\n\n### Behavioral Interventions\n\n#### 1. Abstinence\n - Refraining from any form of sexual activity can significantly reduce the risk of HIV transmission.\n\n#### 2. Sexual Monogamy\n - Engaging in a mutually monogamous relationship with an uninfected partner can minimize the risk of HIV transmission.\n\n#### 3. Condom Use\n - Consistent and correct use of condoms can reduce the risk of HIV transmission by up to 90%.\n\n#### 4. Avoiding Injection Drug Use\n - Refraining from sharing needles or equipment associated with injection drug use can significantly reduce the risk of HIV transmission.\n\n#### 5. Post-Exposure Prophylaxis (PEP)\n - Taking antiretroviral medications immediately after exposure to HIV can reduce the risk of infection.\n\n### Biomedical Interventions\n\n#### 1. Pre-Exposure Prophylaxis (PrEP)\n - Taking antiretroviral medications daily can reduce the risk of HIV infection by up to 90% in individuals who are at high risk.\n\n#### 2. HIV Testing and Counseling\n - Regular HIV testing and counseling can help individuals understand their risk factors and take steps to reduce their risk of infection.\n\n#### 3. Antiretroviral Therapy (ART)\n - Providing ART to individuals living with HIV can reduce the risk of transmission to their sexual partners.\n\n#### 4. Male Circumcision\n - Male circumcision can reduce the risk of HIV transmission by up to 60% in heterosexual men.\n\nBy implementing these behavioral and biomedical interventions, individuals can significantly reduce their risk of HIV infection and prevent the transmission of the virus.",
    "true_answer": "HIV prevention involves several key strategies. To reduce the risk of getting HIV, it is important to use condoms correctly every time during sex. For individuals who inject drugs, avoiding drug use altogether is recommended, but if drugs are used, only sterile injection equipment and water should be used, and equipment should never be shared with others. Pre-exposure prophylaxis (PrEP) is an option for those at risk of HIV, involving either a daily HIV medicine or an injectable HIV medicine every two months to lower the risk of infection through sex or injection drug use. For those already living with HIV, taking antiretroviral therapy (ART) as prescribed can reduce the amount of HIV in the blood to undetectable levels, preventing transmission to sexual partners. To prevent perinatal transmission, individuals with HIV who take HIV medicine as prescribed throughout pregnancy and childbirth reduce the risk of passing HIV to their baby to less than 1%. Additionally, in cases where one partner has HIV, PrEP can help protect both the individual and their baby while trying to conceive, during pregnancy, or while breastfeeding."
  },
  {
    "question": "How frequently ART must be taken?",
    "answer": "## Adherence to Antiretroviral Therapy (ART)\n\n Adherence to Antiretroviral Therapy (ART) is a crucial aspect of HIV treatment. It involves taking the prescribed medication as directed by a healthcare provider to effectively manage the virus and prevent its progression.\n\n ### Importance of Adherence:\n - **Viral Suppression**: Adherence to ART helps in suppressing the HIV virus, preventing its replication, and reducing the risk of transmission.\n - **Prevention of Drug Resistance**: Taking ART as prescribed helps prevent the development of drug-resistant strains of the virus, which can make treatment more challenging.\n\n ### Adherence Guidelines:\n The **World Health Organization (WHO)** and other health organizations recommend the following adherence guidelines:\n\n - **Daily Dosing**: ART must be taken daily to maintain viral suppression.\n - **No Breaks**: There should be no breaks in ART, as this can lead to viral rebound and resistance.\n\n ### Conclusion:\n Adherence to ART is essential for effective HIV management. Taking the prescribed medication daily, without breaks, is critical to prevent viral rebound, resistance, and transmission.",
    "true_answer": "Antiretroviral therapy (ART) must be taken as a pill every day or as a shot once every month or two months."
  },
  {
    "question": "How can we prevent Perinatal transmission of HIV?",
    "answer": "## Preventing Perinatal Transmission of HIV\n\n### General Prevention Strategies\n\nTo prevent perinatal transmission of HIV, the following general measures should be implemented:\n\n#### 1. **Post-Exposure Prophylaxis (PEP)**\n\n- **Appropriate Use**: Administer PEP to HIV-exposed infants immediately after birth.\n- **Reasoning**: PEP helps reduce the risk of HIV transmission to the infant.\n\n#### 2. **Antiretroviral Medication**\n\n- **Use in All Pregnant Women**: Antiretroviral medication should be used in all pregnant women with HIV.\n- **Reasoning**: Antiretroviral medication helps reduce the viral load in the mother's body, thereby reducing the risk of HIV transmission to the infant.\n\n#### 3. **Elective Cesarean Delivery**\n\n- **Indications**: Elective cesarean delivery should be considered if:\n  - The viral load is not suppressed\n  - The mother's viral load is unknown\n  - The mother is not receiving antiretroviral medication\n\n#### 4. **Avoidance of Breastfeeding**\n\n- **Recommendation**: HIV-positive mothers should avoid breastfeeding their infants to prevent postnatal transmission of HIV.\n\n### Specific Prevention Strategies in the United States\n\nIn the United States, the following specific measures can be taken to prevent perinatal transmission of HIV:\n\n#### 1. **HIV Testing**\n\n- **Recommended Testing**: HIV testing should be recommended during each pregnancy, regardless of previous test results.\n- **Early Detection**: Early detection of HIV in pregnant women allows for timely initiation of antiretroviral medication and other preventive measures.\n\n#### 2. **Antiretroviral Medication**\n\n- **Initiation**: Antiretroviral medication should be initiated as soon as possible after diagnosis.\n- **Benefits**: Antiretroviral medication helps reduce the viral load in the mother's body, thereby reducing the risk of HIV transmission to the infant.\n\n#### 3. **Elective Cesarean Delivery**\n\n- **Indications**: Elective cesarean delivery should be considered if:\n  - The viral load is not suppressed\n  - The mother's viral load is unknown\n  - The mother is not receiving antiretroviral medication\n\n#### 4. **Avoidance of Breastfeeding**\n\n- **Recommendation**: HIV-positive mothers should avoid breastfeeding their infants to prevent postnatal transmission of HIV.\n\n#### 5. **Zidovudine Prophylaxis**\n\n- **Infant Prophylaxis**: Zidovudine prophylaxis should be administered to all HIV-exposed infants.\n- **Benefits**: Zidovudine prophylaxis helps reduce the risk of HIV transmission to the infant.\n\nBy implementing these prevention strategies, the risk of perinatal transmission of HIV can be significantly reduced.",
    "true_answer": "To prevent perinatal transmission of HIV, pregnant women should take antiretroviral therapy (ART) throughout pregnancy and childbirth. ART throughout pregnancy and childbirth reduces the chances of perinatal transmission of HIV to less than 1%."
  },
  {
    "question": "What are the main cell types infected with HIV?",
    "answer": "## Cell Types Infected by HIV\n\n Human Immunodeficiency Virus (HIV) primarily targets and infects specific cell types, which play a crucial role in the immune system. Understanding these cell types is essential for grasping the pathogenesis and progression of HIV infection.\n\n ### Key Cell Types Infected by HIV:\n - **CD4+ T Lymphocytes**: Also known as T helper cells, these cells are vital for coordinating the immune response. HIV infection of CD4+ T cells leads to a decline in their numbers, impairing the immune system's ability to fight off infections.\n - **Monocytes/Macrophages**: These cells are part of the innate immune system and play a key role in the initial response to infections. HIV infection of monocytes and macrophages enables the virus to establish reservoirs and evade the immune system.\n\n ### Summary:\n HIV primarily infects CD4+ T lymphocytes and monocytes/macrophages, which are essential components of the immune system. The infection of these cells disrupts the immune response, leading to immunosuppression and the progression of HIV infection to acquired immunodeficiency syndrome (AIDS).",
    "true_answer": "The main cell types found to be infected with HIV are CD4+ T lymphocytes and macrophage-lineage cells."
  },
  {
    "question": "What is the difference between HIV and AIDS?",
    "answer": "## Understanding the Difference Between HIV and AIDS\n\n HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immunodeficiency Syndrome) are two closely related yet distinct conditions. Understanding the difference between them is crucial for effective management and treatment.\n\n ### Key Concepts:\n - **HIV**: A virus that attacks the immune system, specifically the CD4 cells (also known as T cells), which play a vital role in fighting infections.\n - **AIDS**: A condition that occurs when the immune system is severely weakened due to HIV, making the body susceptible to opportunistic infections and cancers.\n\n ### The Relationship Between HIV and AIDS:\n - HIV is the cause of AIDS.\n - AIDS is the most advanced stage of HIV infection, characterized by a CD4 count below 200 cells/mm3 or the presence of an opportunistic infection.\n\n ### Summary:\n HIV is the virus that leads to AIDS, a condition that compromises the immune system, making it difficult for the body to fight off infections and diseases. Early detection and treatment of HIV can prevent the progression to AIDS.",
    "true_answer": "HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. AIDS stands for acquired immunodeficiency syndrome, the most advanced stage of HIV infection."
  },
  {
    "question": "How is HIV not transmitted?",
    "answer": "## HIV Transmission: What You Need to Know\n\n HIV transmission is a complex process, and understanding how it is not transmitted is crucial for prevention and management. Here's a breakdown of the key points:\n\n ### Key Points:\n - **Casual Contact**: HIV is not transmitted through casual contact such as:\n   - Touching\n   - Hugging\n   - Shaking hands\n   - Sharing eating utensils\n   - Drinking glasses\n   - Coughing\n   - Sneezing\n   - Toilet seats\n   - Insect bites\n   - Tears\n   - Sweat\n\n - **Fluids Not Transmitted**: HIV is not transmitted through the following body fluids:\n   - Saliva\n   - Urine\n   - Vomit\n\n ### Summary:\n By understanding how HIV is not transmitted, individuals can take steps to protect themselves and others from infection.",
    "true_answer": "You cannot get HIV from: Air or water. Saliva, tears, sweat, feces, or urine that is not mixed with the blood of a person with HIV. Casual contact with a person who has HIV, such as a handshake, a hug, or a closed-mouth kiss. Contact with objects, such as toilet seats, doorknobs, or dishes used by a person who has HIV. Mosquitoes, ticks, or other biting insects. Other sexual activities that do not involve the exchange of body fluids (for example, touching). HIV can\u2019t be passed through healthy, unbroken skin."
  },
  {
    "question": "What is known about the switch that occurs between patients with latent HIV and active infection?",
    "answer": "## The Switch from Latent to Active HIV Infection\n\n### Understanding the Switch\n\nThe transition from latent to active HIV infection is a critical phase in the disease's progression. This switch is characterized by the emergence of viral variants that are more virulent and resistant to the host's immune response.\n\n### Key Factors in the Switch\n\n#### Genetic Mutation\n\n*   The switch is thought to be driven by genetic mutations, which lead to the emergence of new viral variants with enhanced virulence.\n\n#### Resistance to Host Immune Response\n\n*   The new viral variants are resistant to the host's immune response, allowing them to replicate more efficiently and evade the body's defenses.\n\n#### Enhanced Virulence\n\n*   The emergence of more virulent viral variants is a hallmark of the switch from latent to active infection, contributing to the progression of the disease.\n\n### Summary\n\nThe switch from latent to active HIV infection is a complex process driven by genetic mutations, resistance to the host's immune response, and the emergence of more virulent viral variants. Understanding this switch is essential for developing effective strategies to prevent and treat HIV infection.",
    "true_answer": "The switch between latent and active HIV infection is primarily driven by the activation of HIV provirus within latently infected cells. Latent HIV infection occurs when the virus integrates its genetic material into the host cell's DNA, allowing the virus to persist in a dormant state. In latent infection, viral replication and gene expression are minimal or absent, and the infected cells remain functionally normal. This form of infection is responsible for the long-term persistence of HIV in individuals, even when systemic viral replication is suppressed with antiretroviral therapy (ART). The switch to active HIV infection occurs when the provirus becomes transcriptionally active; this is often triggered by extracellular signals or events that activate the host cell . One possible mechanism for the switch involves the binding of cellular transcription factors, such as nuclear factor kappa B (NF-\u03baB) and nuclear factor of activated T-cells (NFAT), to the HIV long terminal repeat (LTR) region, resulting in the activation of proviral transcription. Other factors that can contribute to the switch include cytokines, chemokines, and cellular activation signals. This transition between latent and active HIV infection plays a critical role in the pathogenesis of the disease, as it is during periods of active infection that the virus replicates and spreads to new cells, ultimately leading to the progressive decline of the host immune system . Understanding the molecular mechanisms involved in the switch from latent to active HIV infection could help inform the development of novel therapeutic strategies aimed at targeting and eliminating latently infected cells, which represent a major obstacle to achieving a cure for HIV."
  }
]